Decision expected in landmark opioid trial against Big Pharma

Ruling in Oklahoma case will determine whether Johnson& Johnson and subsidiary Janssen downplayed addiction risks while marketing opioid painkillers
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news